clinical trial · NCT07209852
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
BradycardiaAtrioventricular BlockSinus Node DysfunctionBundle-Branch BlockPacemaker lead
brief summary
The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.
started
Dec 19, 2025
primary completion
Aug 31, 2029
completion
Aug 31, 2029
last updated
Apr 3, 2026
official title
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up (SEPTA PMCF)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol